WEED Fundamental Analysis - CANOPY GROWTH CORP

Name: CANOPY GROWTH CORP (WEED) Stock
Brand: CANOPY GROWTH CORP
Rating: 2 (3 reviews)

Fundamental Rating

Taking everything into account, WEED scores 2 out of 10 in our fundamental rating. WEED was compared to 32 industry peers in the Pharmaceuticals industry. The financial health of WEED is average, but there are quite some concerns on its profitability. WEED is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year WEED has reported negative net income.

WEED had a negative operating cash flow in the past year.

In the past 5 years WEED always reported negative net income.

In the past 5 years WEED always reported negative operating cash flow.

1.2 Ratios

WEED's Return On Assets of -36.07% is on the low side compared to the rest of the industry. WEED is outperformed by 75.00% of its industry peers.

The Return On Equity of WEED (-52.42%) is worse than 62.50% of its industry peers.

		Industry Rank	Sector Rank
ROA	-36.07%
ROE	-52.42%
ROIC	N/A

ROA(3y)-83.37%

ROA(5y)-56.25%

ROE(3y)-219.63%

ROE(5y)-143.17%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 27.49%, WEED is not doing good in the industry: 62.50% of the companies in the same industry are doing better.

The Profit Margin and Operating Margin are not available for WEED so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	27.49%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

WEED does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for WEED has been increased compared to 1 year ago.

The number of shares outstanding for WEED has been reduced compared to 5 years ago.

WEED has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -9.51, we must say that WEED is in the distress zone and has some risk of bankruptcy.

WEED has a Altman-Z score of -9.51. This is in the lower half of the industry: WEED underperforms 78.13% of its industry peers.

WEED has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.

WEED's Debt to Equity ratio of 0.33 is in line compared to the rest of the industry. WEED outperforms 50.00% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.33
Debt/FCF	N/A
Altman-Z	-9.51

ROIC/WACCN/A

WACC10.47%

2.3 Liquidity

WEED has a Current Ratio of 5.50. This indicates that WEED is financially healthy and has no problem in meeting its short term obligations.

With an excellent Current ratio value of 5.50, WEED belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.

A Quick Ratio of 4.23 indicates that WEED has no problem at all paying its short term obligations.

With an excellent Quick ratio value of 4.23, WEED belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	5.5
Quick Ratio	4.23

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 58.25% over the past year.

Looking at the last year, WEED shows a decrease in Revenue. The Revenue has decreased by -0.67% in the last year.

WEED shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.57% yearly.

EPS 1Y (TTM)58.25%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%99.32%

Revenue 1Y (TTM)-0.67%

Revenue growth 3Y-19.22%

Revenue growth 5Y-7.57%

Sales Q2Q%5.86%

3.2 Future

WEED is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.29% yearly.

The Revenue is expected to grow by 7.39% on average over the next years.

EPS Next Y88.6%

EPS Next 2Y38.96%

EPS Next 3Y25.31%

EPS Next 5Y15.29%

Revenue Next Year8.32%

Revenue Next 2Y5.98%

Revenue Next 3Y7.77%

Revenue Next 5Y7.39%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

WEED reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year WEED is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as WEED's earnings are expected to grow with 25.31% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y38.96%

EPS Next 3Y25.31%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

WEED does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CANOPY GROWTH CORP

TSX:WEED (11/21/2025, 7:00:00 PM)

1.56

+0.12 (+8.33%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryPharmaceuticals

Earnings (Last)11-07 2025-11-07/bmo

Earnings (Next)02-05 2026-02-05/bmo

Inst Owners5.58%

Inst Owner ChangeN/A

Ins Owners0.13%

Ins Owner ChangeN/A

Market Cap527.67M

Revenue(TTM)278.61M

Net Income(TTM)-385.85M

Analysts46.15

Price Target3.77 (141.67%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)51.01%

Min EPS beat(2)8.22%

Max EPS beat(2)93.8%

EPS beat(4)2

Avg EPS beat(4)-51.44%

Min EPS beat(4)-206.63%

Max EPS beat(4)93.8%

EPS beat(8)2

Avg EPS beat(8)-152.68%

EPS beat(12)3

Avg EPS beat(12)-166.46%

EPS beat(16)4

Avg EPS beat(16)-163.73%

Revenue beat(2)1

Avg Revenue beat(2)0.9%

Min Revenue beat(2)-7.76%

Max Revenue beat(2)9.57%

Revenue beat(4)3

Avg Revenue beat(4)3.88%

Min Revenue beat(4)-7.76%

Max Revenue beat(4)9.57%

Revenue beat(8)5

Avg Revenue beat(8)2.85%

Revenue beat(12)6

Avg Revenue beat(12)1.1%

Revenue beat(16)8

Avg Revenue beat(16)-0.85%

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)70.39%

EPS NQ rev (3m)70.39%

EPS NY rev (1m)7.19%

EPS NY rev (3m)7.19%

Revenue NQ rev (1m)-8.94%

Revenue NQ rev (3m)-8.94%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.89
P/FCF	N/A
P/OCF	N/A
P/B	0.72
P/tB	0.87
EV/EBITDA	N/A

EPS(TTM)-2.81

EYN/A

EPS(NY)-0.39

Fwd EYN/A

FCF(TTM)-0.28

FCFYN/A

OCF(TTM)-0.26

OCFYN/A

SpS0.82

BVpS2.18

TBVpS1.79

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-36.07%
ROE	-52.42%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	27.49%
FCFM	N/A

ROA(3y)-83.37%

ROA(5y)-56.25%

ROE(3y)-219.63%

ROE(5y)-143.17%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score5

Asset Turnover0.26

Health

		Industry Rank	Sector Rank
Debt/Equity	0.33
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	18.94%
Cap/Sales	2.77%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	5.5
Quick Ratio	4.23
Altman-Z	-9.51

F-Score5

WACC10.47%

ROIC/WACCN/A

Cap/Depr(3y)15.39%

Cap/Depr(5y)45.04%

Cap/Sales(3y)2.72%

Cap/Sales(5y)9.89%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)58.25%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%99.32%

EPS Next Y88.6%

EPS Next 2Y38.96%

EPS Next 3Y25.31%

EPS Next 5Y15.29%

Revenue 1Y (TTM)-0.67%

Revenue growth 3Y-19.22%

Revenue growth 5Y-7.57%

Sales Q2Q%5.86%

Revenue Next Year8.32%

Revenue Next 2Y5.98%

Revenue Next 3Y7.77%

Revenue Next 5Y7.39%

EBIT growth 1Y51.22%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year86.74%

EBIT Next 3Y33.06%

EBIT Next 5Y21.05%

FCF growth 1Y81.5%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y82.69%

OCF growth 3YN/A

OCF growth 5YN/A

CANOPY GROWTH CORP / WEED.CA FAQ

Can you provide the ChartMill fundamental rating for CANOPY GROWTH CORP?

ChartMill assigns a fundamental rating of 2 / 10 to WEED.CA.

What is the valuation status for WEED stock?

ChartMill assigns a valuation rating of 1 / 10 to CANOPY GROWTH CORP (WEED.CA). This can be considered as Overvalued.

How profitable is CANOPY GROWTH CORP (WEED.CA) stock?

CANOPY GROWTH CORP (WEED.CA) has a profitability rating of 0 / 10.

CANOPY GROWTH CORP (WEED.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

CANOPY GROWTH CORP / WEED.CA FAQ

Can you provide the ChartMill fundamental rating for CANOPY GROWTH CORP?

What is the valuation status for WEED stock?

How profitable is CANOPY GROWTH CORP (WEED.CA) stock?